CJC + Ipamorelin (5mg/5mg) Injectable

Enhanced Muscle Growth and Recovery: The combined action of CJC-1295 and Ipamorelin significantly boosts growth hormone production, leading to increased muscle growth and faster recovery, making it ideal for athletes and those seeking to build lean muscle mass.

Fat Loss and Improved Metabolism: The peptides enhance metabolism, promoting fat reduction, particularly in stubborn areas. This effect helps improve body composition and supports weight loss goals.

Improved Sleep Quality: CJC-1295/Ipamorelin promotes deeper, more restorative sleep, which is crucial for effective recovery and overall well-being.

Anti-Aging and Longevity: By increasing growth hormone levels, this combination supports cell regeneration and reduces visible signs of aging such as wrinkles and loose skin, enhancing overall skin health and longevity.

Tissue Repair and Recovery from Injury: The combination supports faster healing of muscles, tendons, and ligaments, making it useful for individuals recovering from injuries or intense physical activity.

Active Cancer: As CJC-1295 and Ipamorelin stimulate growth hormone production, individuals with active cancer should avoid these peptides.

Pregnant or Breastfeeding Women: The safety of CJC-1295 and Ipamorelin during pregnancy or breastfeeding has not been established, and thus they should not be used by these populations.

Muscle growth and maintenance

Fat loss and improved metabolism

Anti-aging and longevity

Sleep quality and recovery

Athletic performance enhancement

Faster recovery from physical exertion

Tissue repair and injury recovery

Energy and stamina improvement

Skin elasticity and collagen production

Cognitive clarity and focus

Hormonal balance and growth hormone optimization

Reduced inflammation and joint discomfort

Circadian rhythm alignment

Weight management support

Metabolic health optimization

Immune system enhancement

Stress resilience and mood stabilization

Post-surgical or injury rehabilitation

Muscle soreness and fatigue reduction

Improved endurance and physical performance

DOSING:

0.25 mg = 20 units per injection.

INJECTIONS PER WEEK: 

5 injections weekly.

VIAL DETAILS:

5mg / 5mg reconstituted with 4mL of bacteriostatic water.

Concentration: 1.25mg/mL

Duration: Lasts ~4 weeks at when following standard dosing protocol.

RECOMMENDED CYCLES:

3 months on (+), 1 month off (-). 

3 cycles per year.

INJECTION SITE:

Administer injections into subcutaneous fat (such as the stomach, thigh, or arm).

TIME OF DAY:

CJC/Ipamorelin is typically injected in the evening or before bedtime, ideally 2 hours after your last meal. 

This aligns with the body's natural peak in growth hormone release during sleep, enhancing effectiveness.

Injection Site Reactions: Common side effects include redness, swelling, or mild discomfort at the injection site, which typically resolve on their own.

Mild Flu-Like Symptoms: Some users report fatigue, headache, or nausea, particularly during initial use.

Increased Hunger and Appetite Changes: Ipamorelin, due to its ghrelin-mimicking action, can lead to increased appetite.

Please contact us if you experience any of the following:

• Fever of 100.4°F (38°C) or higher
• Blistering at the injection site
• Muscle aches, nausea, dizziness, or headache
• Skin rash, severe itching, vomiting, or hives

If you have any questions, please message your healthcare provider through the patient portal or contact us at 646-596-7386.

Start with a Lower Dose: Gradually increase the dose to minimize the risk of side effects.

Rotate Injection Sites: This helps prevent irritation and reduces the risk of injection site reactions.

Take Before Bedtime: Administering the injection before sleep can help align with the body’s natural growth hormone release and potentially reduce unwanted side effects.

Take 1-2 hours after your last meal

Consult a Healthcare Provider Regularly: Professional guidance ensures proper dosage adjustments and monitoring of any adverse reactions, which is crucial for safe and effective use.

1-2 Weeks: Initial improvements in sleep quality and energy levels are often noted, as growth hormone begins to influence circadian rhythms.

4-6 Weeks: Users typically experience increased muscle definition, fat loss, and better recovery from physical activity. Anecdotal evidence suggests that within this time frame, significant changes in body composition become apparent.

8-12 Weeks: Long-term benefits, such as enhanced muscle mass, reduced visceral fat, improved skin elasticity, and overall anti-aging effects, become more prominent. A consistent increase in vitality and well-being is also reported.

Long-Term: Continuous use under medical supervision can lead to sustained improvements in physical health, hormonal balance, and metabolic functions, which contributes to better body composition and aging outcomes.

CJC-1295 is a growth hormone-releasing hormone (GHRH) analog that stimulates the pituitary gland to release growth hormone in a controlled, sustained manner. By extending the half-life of GHRH, CJC-1295 ensures a prolonged and rhythmic elevation of growth hormone levels in the body. Ipamorelin, a growth hormone secretagogue, complements CJC-1295 by directly signaling the pituitary gland to trigger a sharp yet targeted growth hormone release. Unlike some other peptides, Ipamorelin specifically activates growth hormone without significantly impacting cortisol or other stress hormones.

Together, these peptides mimic the body’s natural growth hormone cycles, delivering a balanced boost that enhances muscle growth, fat metabolism, tissue repair, and overall cellular regeneration. This synergy supports a range of health benefits, from anti-aging effects to improved physical performance and recovery.